Troglitazone regulates peroxisome proliferator-activated receptors and inducible nitric oxide synthase in murine ovarian macrophages

Biology of Reproduction

Volumn 74, Issue 1, 2006, Pages 153-160

  Minge, Cadence E ^a   Ryan, Natalie K ^a   Van Der Hoek, Kylie H ^a   Robker, Rebecca L ^a   Norman, Robert J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cytokines; Immunology; Ovary

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CHORIONIC GONADOTROPIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CELL TYPE; CONTROLLED STUDY; CORPUS LUTEUM; DOWN REGULATION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; FEMALE; GENE; GENE EXPRESSION REGULATION; GRANULOSA CELL; HORMONE RESPONSE; IMMUNOCOMPETENT CELL; INSULIN RESISTANCE; MACROPHAGE; METABOLIC REGULATION; MOUSE; NONHUMAN; NOS2 GENE; OVARY CYCLE; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; OVULATION; PERITONEUM MACROPHAGE; PPARA GENE; PPARG GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; STROMA CELL; SYMPTOMATOLOGY; THECA CELL;

ANIMALS; BLOTTING, WESTERN; CHROMANS; FEMALE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1; MACROPHAGES; MICE; NITRIC OXIDE SYNTHASE TYPE II; OVARY; OVULATION; PPAR ALPHA; PPAR GAMMA; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIAZOLIDINEDIONES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MURINAE;

EID: 30344481981     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.105.043729     Document Type: Article

References (48)

1. Mudaliar S, Henry RR. New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers. Annu Rev Med 2001; 52:239-257.
2. Picard F, Auwerx J. PPAR(gamma) and glucose homeostasis. Annu Rev Nutr 2002; 22:167-197.
3. Ehrmann DA, Schneider DJ, Sobel BE, Cavaghan MK, Imperial J, Rosenfield RL, Polonsky KS. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82:2108-2116.
4. Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ. Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 2002; 77:209-215.
5. Norman RJ. Hyperandrogenaemia and the ovary. Mol Cell Endocrinol 2002; 191:113-119.
6. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999; 20:649-688.
7. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med 2002; 53:409-435.
8. Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 2000; 49:497-505.
9. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391:82-86.
10. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 1996; 384:39-43.
11. Delerive P, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 2001; 169:453-459.
12. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996; 137:354-366.
13. Sundvold H, Brzozowska A, Lien S. Characterisation of bovine peroxisome proliferator-activated receptors gamma 1 and gamma 2: genetic mapping and differential expression of the two isoforms. Biochem Biophys Res Commun 1997; 239:857-861.
14. Mu YM, Yanase T, Nishi Y, Waseda N, Oda T, Tanaka A, Takayanagi R, Nawata H. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. Biochem Biophys Res Commun 2000; 271:710-713.
15. Cui Y, Miyoshi K, Claudio E, Siebenlist UK, Gonzalez FJ, Flaws J, Wagner KU, Hennighausen L. Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chetn 2002; 277:17830-17835.
16. Froment P, Fabre S, Dupont J, Pisselet C, Chesneau D, Staels B, Monget P. Expression and functional role of peroxisome proliferator-activated receptor-{gamma} in ovarian folliculogenesis in the sheep. Biol Reprod 2003; 69:1665-1674.
17. Lohrke B, Viergutz T, Shahi SK, Pohland R, Wollenhaupt K, Goldammer T, Walzel H, Kanitz W. Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor gamma in lutein cells. J Endocrinol 1998; 159:429-439.
18. Schoppee PD, Garmey JC, Veldhuis JD. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod 2002; 66:190-198.
19. Komar CM, Braissant O, Wahli W, Curry TE Jr.. Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology 2001; 142:4831-4838.
20. Komar CM, Curry TE Jr.. Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferator-activated receptor gamma and P450 side chain cleavage in the rat ovary. Biol Reprod 2003; 69:549-555.
21. Wu XK, Zhou SY, Liu JX, Pollanen P, Sallinen K, Makinen M, Erkkola R. Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. Fertil Steril 2003; 80:954-965.
22. Chinetti G, Griglio S, Antonucci M, Torra IP, Delerive P, Majd Z, Fruchart JC, Chapman J, Najib J, Staels B. Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 1998; 273 25573-25580.
23. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391:79-82.
24. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93:241-252.
25. Huang JT, Welch JS, Ricote M, Binder CJ, Willson TM, Kelly C, Witztum JL, Funk CD, Conrad D, Glass CK. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999; 400:378-382.
26. Moore KJ, Rosen ED, Fitzgerald ML, Randow F, Andersson LP, Altshuler D, Milstone DS, Mortensen RM, Spiegelman BM, Freeman MW. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat Med 2001; 7:41-47.
27. Alleva DG, Johnson EB, Lio FM, Boehme SA, Conlon PJ, Crowe PD. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: counter-regulatory activity by IFN-gamma. J Leukoc Biol 2002; 71:677-685.
28. Espey LL. Ovulation as an inflammatory reaction - a hypothesis. Biol Reprod 1980; 22:73-106.
29. Sasson R, Winder N, Kees S, Amsterdam A. Induction of apoptosis in granulosa cells by TNF alpha and its attenuation by glucocorticoids involve modulation of Bcl-2. Biochem Biophys Res Commun 2002; 294: 51-59.
30. Bonello N, McKie K, Jasper M, Andrew L, Ross N, Braybon E, Brannstrom M, Norman RJ. Inhibition of nitric oxide: effects on interleukin-1 beta-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biol Reprod 1996; 54:436-445.
31. Keenihan SN, Robertson SA. Diversity in phenotype and steroid hormone dependence in dendritic cells and macrophages in the mouse uterus. Biol Reprod 2004; 70:1562-1572.
32. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
33. Hume DA, Ross IL, Himes SR, Sasmono RT, Wells CA, Ravasi T. The mononuclear phagocyte system revisited. J Leukoc Biol 2002; 72:621-627.
34. van den Berg TK, Kraal G. A function for the macrophage F4/80 molecule in tolerance induction. Trends Immunol 2005; 26:506-509.
35. Van der Hoek KH. Ovarian macrophages and the regulation of ovarian function. Adelaide: University of Adelaide; 2004. Thesis.
36. Von Der Hardt K, Kandler MA, Fink L, Schoof E, Dotsch J, Bohle RM, Rascher W. Laser-assisted microdissection and real-time PCR detect anti-inflammatory effect of perfluorocarbon. Am J Physiol Lung Cell Mol Physiol 2003; 285:L55-L62.
37. Komar CM, Curry TE Jr.. Localization and expression of messenger RNAs for the peroxisome proliferator-activated receptors in ovarian tissue from naturally cycling and pseudopregnant rats. Biol Reprod 2002; 66: 1531-1539.
38. Bukulmez O, Arici A. Leukocytes in ovarian function. Hum Reprod Update 2000; 6:1-15.
39. Wu R, Van der Hoek KH, Ryan NK, Norman R, Robker RL. Macrophage contributions to ovarian function. Hum Reprod Update 2004; 10:119-133.
40. Norman RJ, Brannstrom M. Cytokines in the ovary: pathophysiology and potential for pharmacological intervention. Pharmacol Ther 1996; 69:219-236.
41. Perrey S, Ishibashi S, Yahagi N, Osuga J, Tozawa R, Yagyu H, Ohashi K, Gotoda T, Harada K, Chen Z, Iizuka Y, Shionoiri F, Yamada N. Thiazolidinedione- and tumor necrosis factor alpha-induced downregulation of peroxisome proliferator-activated receptor gamma mRNA in differentiated 3T3-L1 adipocytes. Metabolism 2001; 50:36-40.
42. Davies GF, Khandelwal RL, Roesler WJ. Troglitazone induces expression of PPARgamma in liver. Mol Cell Biol Res Commun 1999; 2:202-208.
43. Davies GF, McFie PJ, Khandelwal RL, Roesler WJ. Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes. J Pharmacol Exp Ther 2002; 300:72-77.
44. Wang M, Wise SC, Leff T, Su TZ. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma. Diabetes 1999; 48: 254-260.
45. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001; 7:48-52.
46. Park EJ, Park SY, Joe EH, Jou I. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. J Biol Chem 2003; 278:14747-14752.
47. Richards JS, Russell DL, Ochsner S, Hsieh M, Doyle KH, Falender AE, Lo YK, Sharma SC. Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res 2002; 57:195-220.
48. Shibata T, Kondo M, Osawa T, Shibata N, Kobayashi M, Uchida K. 15-deoxy-delta 12,14-prostaglandin J2: a prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem 2002; 277: 10459-10466.